| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| fda approvals 2022 | 1.07 | 0.3 | 2295 | 61 | 18 |
| fda | 1.67 | 0.7 | 8819 | 42 | 3 |
| approvals | 1.76 | 1 | 8604 | 68 | 9 |
| 2022 | 1.51 | 0.2 | 8659 | 84 | 4 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| fda approvals 2022 | 0.61 | 0.4 | 8263 | 86 |
| fda approvals 2020 | 2 | 1 | 686 | 76 |
| fda approvals 2023 | 1.79 | 1 | 4768 | 8 |
| fda approvals 2021 | 0.79 | 0.7 | 1276 | 75 |
| fda approvals 2024 | 0.07 | 0.8 | 7339 | 60 |
| fda drug approvals 2022 | 1.12 | 0.7 | 1467 | 81 |
| fda new drug approvals 2022 | 0.95 | 0.3 | 8162 | 30 |
| teplizumab fda approval 2022 | 0.26 | 0.8 | 2244 | 99 |
| fda new drug therapy approvals 2022 | 0.17 | 0.1 | 8179 | 56 |
| fda accelerated approvals 2022 | 0.23 | 0.2 | 184 | 42 |
| tirzepatide fda approval 2022 | 1 | 0.9 | 7762 | 66 |
| pacritinib fda approval 2022 | 1.7 | 0.7 | 4497 | 73 |
